Research Creative   My Account   Submit My Manuscript
Letpub, Scientific Editing Services, Manuscript Editing Service

Scientific Journal Selector



CANCER LETTERS


👁  357404 Views

 1442 Reviews  

 Open Access      SCIE      Official Website     Submission Website
Return to Search
 

*Average Peer Review
About 2.7 month(s)
*Competitiveness
About 52.27%
CiteScore
17.7

CiteScore Rank
Subject Area Rank Percentile
Category: Medicine
Subcategory: Oncology
26 / 404
93%
Category: Medicine
Subcategory: Cancer Research
19 / 230
91%



Country/Area of Publication
NETHERLANDS
Publication Frequency
Biweekly
Publisher
Elsevier Ireland Ltd

ISSN
0304-3835
E-ISSN
1872-7980
Year Publication Started
1975

Self-citation (2023-2024)
6.60%
Annual Article Volume
279
Gold OA Percentage
21.55%


Open Access Info
APC APC Waiver Other Charges
N/A N/A N/A

Journal Aim & Scope
CANCER LETTERS is a journal providing rapid publication of full-length articles in the broad area of cancer research. The journal places emphasis on the molecular and cell biology of cancer, oncogenes, carcinogenesis, radiation biology, molecular pathology, hormones and cancer, viral oncology, biology of cancer and metastasis, molecular cytogenetics, epidemiology; and experimental therapeutics. The primary criterion for publication is interest to a multidisciplinary audience. Papers should be technically sound and substantiated by sufficient experimental detail. Clinical papers will be accepted if they contribute to the understanding of the basic mechanisms underlying disease.


Web of Science Quartiles
WOS Quartile: Q1

Quartiles By JIFCollectionQuartileRankPercentage
Category: ONCOLOGYSCIEQ133/322
89.9%
Quartiles By JCICollectionQuartileRankPercentage
Category: ONCOLOGYSCIEQ130/322
90.84%
*Crowdsourced data
  • Journals In The Same Subject Area
  • CiteScore Trends
  • Self Citation Trends
  • Annual Article Volume Trends
  • Journal Title h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144873.20
    Nature Reviews Clinical Oncology12799.40
    NATURE REVIEWS CANCER396111.90
    ANNALS OF ONCOLOGY21063.90
    CANCER CELL29555.20
    JOURNAL OF CLINICAL ONCOLOGY49441.20
    LANCET ONCOLOGY27462.10
    CANCER RESEARCH41116.10
    SEMINARS IN CANCER BIOLOGY13426.80
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH6718.20
  • CANCER LETTERS CANCER LETTERS
    Predict CiteScore Trend:
    Steady Increase No Change Gradual Decline  Refresh
 
    👁  357404 Views
      1442 Reviews        
 
 
 

Select your rating and start your review of CANCER LETTERS

 

    lucky25
    Status: N/A

    2025-03-14

    May I ask how to see the specific number of reviewers? Will the system display it? Mine has always shown "under review".




    Hang Li
    Status: N/A

    2025-03-02

    Could you please confirm if you submitted a review article? It was submitted to the journal on February 24, 2025, with the editor on February 25, 2025, under review on February 26, 2025, and invited 9 but 1 on February 26, 2025, and invited 6 but 2 on March 1, 2025. This is my current status.




    未定形式
    Status: Accepted

    2025-02-06

    Record the outrageous submission experience
    11.29, the submission was rejected, feeling bad at the time, I directly sent an email to the editor-in-chief to criticize the editor who rejected the submission, and also explained the innovative points and advantages of my article. As a result, that evening I received an email saying the article was pulled back and assigned to a different editor for reevaluation.
    12.18, found four reviewers, three requested major revisions and one exceeded the deadline. The feedback from the three reviewers who requested major revisions was very detailed, and the editor provided guidance for the revisions.
    1.20, revised
    2.3, article accepted
    It can only be said that courage is also a necessary emotion for submitting articles.




    未定形式
    Status: Rejected

    2024-11-29

    The focus is on tumor metabolism. I was disgusted by this journal. I wrote the first review article in the relevant field, and the experimental articles in this field now are all top journals with at least 10+ impact factors. The editor directly replied with "the concept is not advanced enough," but I don't understand where the concept is not advanced.




    风啸俊衡
    Status: N/A

    2024-10-23

    Review speed: 1.0 | Submission hit rate: 50.0
    Research focus: Tumor; Drug resistance mechanism
    Experience sharing:
    05.22 Submitted to Journal
    05.22 With editor
    05.24 Under review
    06.14 Required reviews completed
    06.18 Major revision

    The first reviewer gave a month for the first review. The first reviewer provided more than 20 detailed opinions, all of which were easily resolved. The second reviewer had one suggestion, requesting a change in animal model for validation. To meet the second reviewer's request, the revision time was extended by two months.
    09.17 Revision Submitted to Journal
    09.20 Under review
    09.27 Required reviews completed
    10.01 Minor revision

    The second review gave 7 days for revision. The first reviewer believed it was almost suitable for publication, but based on the revision note, provided three additional opinions, including adding text explanations and supplementary data. The second reviewer believed it was acceptable for publication.
    10.07 Revision Submitted to Journal
    10.08 With Editor
    10.13 Under review
    10.15 Required reviews completed

    The pace of the third review is clearly slower, and it is unknown when feedback will be received, causing anxiety.




    通幽阉茂
    Status: N/A

    2024-10-15

    Connect connect connect.




    是你的庆娇呀
    Status: N/A

    2024-10-14

    How are you now? Please update your status.




    风啸俊衡
    Status: N/A

    2024-10-07

    Submissions Being Processed. You should see your submitted articles here.




    魔都吉星
    Status: N/A

    2024-10-05

    Did you receive the email confirming the successful submission of the manuscript? I submitted it in January this year and it is still under review.




    神照正阳
    Status: N/A

    2024-10-01

    After I submitted, I logged into the corresponding author account and couldn't see the article I submitted. What's going on? Please help~~ Submissions Waiting for Author's Approval (0)




Journals In The Same Field
CA-A CANCER JOURNAL FOR CLINICIANS
CiteScore: 873.20

LANCET
CiteScore: 148.10

NEW ENGLAND JOURNAL OF MEDICINE
CiteScore: 145.40

NATURE REVIEWS DRUG DISCOVERY
CiteScore: 137.40

NATURE REVIEWS CANCER
CiteScore: 111.90

NATURE MEDICINE
CiteScore: 100.90

Nature Reviews Clinical Oncology
CiteScore: 99.40

NATURE REVIEWS IMMUNOLOGY
CiteScore: 93.40

Lancet Respiratory Medicine
CiteScore: 87.10

Nature Reviews Disease Primers
CiteScore: 76.70



© 2010-2025  ACCDON LLC 400 5th Ave, Suite 530, Waltham, MA 02451, USA
PrivacyTerms of Servic